ICMR and Panacea Biotec initiate the first dengue vaccine Phase 3 Clinical Trial in India
This landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.